Role of tapentadol in pain management

被引：3
作者：
Mendis, Victor [1 ]
机构：
[1] Mid Essex Hosp NHS Trust, Broomfield Hosp, Chelmsford CM1 7ET, Essex, England
来源：
BRITISH JOURNAL OF HOSPITAL MEDICINE | 2012年 / 73卷 / 03期
关键词：
LOW-BACK-PAIN; DOUBLE-BLIND; EXTENDED-RELEASE; IMMEDIATE-RELEASE; PHASE-III; EFFICACY; PLACEBO; SAFETY; OSTEOARTHRITIS; TOLERABILITY;
D O I：
10.12968/hmed.2012.73.3.143
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
This article reviews tapentadol, a novel centrally-acting opioid analgesic that exerts its analgesic effects through mu-opioid receptor agonism and additionally via noradrenaline reuptake inhibition. This potentially gives it a role in the treatment of both nociceptive and neuropathic pain.
引用
收藏
页码：143 / 147
页数：5
相关论文
共 24 条
  • [1] Efficacy and Safety of Tapentadol Extended Release Compared with Oxycodone Controlled Release for the Management of Moderate to Severe Chronic Pain Related to Osteoarthritis of the Knee A Randomized, Double-Blind, Placebo- and Active-Controlled Phase III Study
    Afilalo, Marc
    Etropolski, Mila S.
    Kuperwasser, Brigitte
    Kelly, Kathy
    Okamoto, Akiko
    Van Hove, Ilse
    Steup, Achim
    Lange, Bernd
    Rauschkolb, Christine
    Haeussler, Juergen
    [J]. CLINICAL DRUG INVESTIGATION, 2010, 30 (08) : 489 - 505
  • [2] Efficacy and safety of tapentadol extended release for the management of chronic low back pain: results of a prospective, randomized, double-blind, placebo- and active-controlled Phase III study
    Buynak, Robert
    Shapiro, Douglas Y.
    Okamoto, Akiko
    Van Hove, Ilse
    Rauschkolb, Christine
    Steup, Achim
    Lange, Bernd
    Lange, Claudia
    Etropolski, Mila
    [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2010, 11 (11) : 1787 - 1804
  • [3] Carter Gregory T, 2002, Curr Opin Investig Drugs, V3, P454
  • [4] A randomized, double-blind, placebo-controlled phase 3 study of the relative efficacy and tolerability of tapentadol IR and oxycodone IR for acute pain
    Daniels, Stephen
    Casson, Ed
    Stegmann, Jens-Ulrich
    Oh, Charles
    Okamoto, Akiko
    Rauschkolb, Christine
    Upmalis, David
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2009, 25 (06) : 1551 - 1561
  • [5] Daniels SE, 2009, CURR MED RES OPIN, V25, P765, DOI [10.1185/03007990902728183, 10.1185/03007990902728183 ]
  • [6] Grunenthal Ltd, 2011, SUMM PROD CHAR PAL S
  • [7] Grunenthal Ltd, 2011, SUMM PROD CHAR PAL 5
  • [8] Hale M, 2009, CURR MED RES OPIN, V25, P1095, DOI [10.1185/03007990902816970, 10.1185/03007990902816970 ]
  • [9] Efficacy and Tolerability of Tapentadol Immediate Release and Oxycodone HCl Immediate Release in Patients Awaiting Primary Joint Replacement Surgery for End-Stage Joint Disease: A 10-Day, Phase III, Randomized, Double-Blind, Active- and Placebo-Controlled Study
    Hartrick, Craig
    Van Hove, Ilse
    Stegmann, Jens-Ulrich
    Oh, Charles
    Upmalis, David
    [J]. CLINICAL THERAPEUTICS, 2009, 31 (02) : 260 - 271
  • [10] Tapentadol and its two mechanisms of action: Is there a new pharmacological class of centrally-acting analgesics on the horizon?
    Kress, Hans G.
    [J]. EUROPEAN JOURNAL OF PAIN, 2010, 14 (08) : 781 - 783
123